Share |

treatment

The disruptive tech firm aiming to reduce the need for cataract surgery

March 31, 2022

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum, chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

Medtech company Edinburgh Biosciences (EBS) is working towards a global solution for the diagnosis and treatment of cataracts. Using a new light-based non-surgical treatment, this cutting-edge treatment has already proved effective in clinical trials.

Ahead of presenting at the 32nd edition of the MedTech investing (MTi) forum on June 6 and 7, Edinburgh Biosciences’ chief executive officer Dr Graham Bell, explains the benefits and potential future applications of the technology.

How to give equal opportunities to employees in family businesses?

November 30, 2021

The nature of the family business human capital is complex. Family and non-family employees have the potential to offer unique and distinct contributions to the firm. Yet some human resources practices might be perceived as a preferential treatment to family employees over non-family ones.

This could be detrimental to the reputation of family business, being perceived as socially irresponsible, and potentially limiting their ability to attract qualified nonfamily employees, which could ultimately affect the company’s long-term performance.

Get the basics right in family business employment law

November 3, 2021

Family businesses often grow in an unstructured way, leading to a culture of informality. As a result, basic employment law documents can get overlooked and family members are not issued with employment contracts or subject to formal policies. This can leave the business exposed when issues arise as neither the business nor the family member have a ‘rule book’ to follow.

Healthcare startups, Esophageal treatment, hybrid air vehicles and water sustainability at next Campden Wealth funds and direct investments webinar

October 13, 2021

Exclusive proposals for early-stage healthcare companies fund, a novel esophagus therapy, a hybrid-electric airship and sustainable investments in water conservation will be heard by qualifying family offices and private investors at the latest virtual Campden Wealth Funds and Direct Investments Event on 21 October.

Each of the four investment opportunities will be introduced in 15-minute slots to all family offices and investors online who will be able to ask questions and discuss the potential returns.

The challenges for global healthcare systems

June 25, 2021

As if healthcare systems around the world were not under huge pressure already, the Coronavirus pandemic has stretched healthcare systems to, and in cases, beyond their limit. Many systems have been forced to cancel routine operations and postpone in person appointments and diagnostic tests.

In the United Kingdom, which has the highest vaccination rate amongst large countries, the British Medical Association (BMA) estimates in the UK between April 2020 and March 2021 there were:

Covid-19 takes mental health toll on family business leaders and next generations

January 27, 2021

Covid-19, Brexit, Black Lives Matter, climate change and the threats to US democracy have created a once in a lifetime opportunity for family next generations to cultivate their “grit”, says a leading family clinical and consulting psychotherapist.

Life-improving healthcare solutions and funds at MedTech Investing Europe Conference

October 6, 2020

Migraine and cataract therapies and a transit solution for vaccines such as Covid-19 are among the new cutting-edge innovations to be presented in the virtual 30th MedTech Investing Europe Conference on 21-22 October, 2020.

Life-saving cancer breakthroughs are in the DNA of LXRepair

June 1, 2020

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

LXRepair will present to global investors its new approach to personalised cancer therapies at the Campden Wealth MedTech Investing Europe Conference in September 2020.

The French medtech company is pioneering the development of functional comprehensive DNA repair and DDR assay and has researched the science behind DNA repair mechanisms and in vitro diagnostics for cancer over the past 25 years.